Clinical Trials Directory
This study follows about 40 mothers and their children who have a condition called tuberous sclerosis complex. The children are 10 years old or younger. The study looks at information from pregnancies, including whether the mother took certain medicines during pregnancy or not. To take part, participants will give consent online, have a short phone call, and complete surveys. With permission, the study team will collect medical records about the pregnancy and the child’s health from birth to now. There are no in person visits, treatments, or procedures. The study only collects information to help doctors learn more about how this condition and certain medicines may affect pregnancy and children.
This study is being done to find out if atropine eyedrops (0.05% atropine, 99.95% inactive solution) and/or special eyeglass lenses are an effective strategy to slow down the progression of myopia for young children with nearsightedness.
We are doing this study to compare the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib. We want to find out if adding gilteritinib to the usual treatment is beneficial for people with acute myeloid leukemia (AML).
We are doing this study to find out if 2 different experimental drug combinations can improve outcomes for people who are newly diagnosed with AML. We want to compare the outcomes from the standard treatment (cytarabine + daunorubicin) to the following experimental regimens:
- Venetoclax + cytarabine + daunorubicin
- Venetoclax + azacitidine
We are doing this study to compare different experimental drug regimens to the usual treatment (cytarabine and daunorubicin) for acute myeloid leukemia (AML). We want to find out which options have the best outcomes. The different drug combinations we will be testing against the usual treatment are:
- daunorubicin and cytarabine liposome
- cytarabine and daunorubicin with venetoclax
- azacitidine and venetoclax
- daunorubicin and cytarabine liposome with venetoclax
We are doing this study to see if blood and bone marrow samples can be tested in a timely manner that allows for the detection of certain markers that could guide cancer treatment.
We are using you or your child's medical information in this study to better understand the diagnosis, treatment, and complications of Spina Bifida.
We created the Registry for Brain Health to help you improve your brain health and get involved in research studies. The number of people in North Carolina affected by memory disorders, such as Alzheimer's disease and other forms of dementia, is going up. To change that, we must work together, stay informed, and get involved. We are enrolling both people who have memory problems and people who are healthy and do not have memory problems.